Satellite Symposium: The Latest Advancements in Achondroplasia

This virtual symposium, sponsored by BioMarin Pharmaceutical Inc., will address the latest advancements in achondroplasia, the most common form of disproportionate short stature, or dwarfism. In a panel discussion, experts will review the underlying cause of achondroplasia, share key information and news that you and your practice should know, and discuss pediatric endocrinology's evolving role in the care of children with this condition.